Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 7898 | 17.28 |
09:33 ET | 1423 | 17.54 |
09:35 ET | 400 | 17.36 |
09:37 ET | 200 | 17.44 |
09:39 ET | 100 | 17.46 |
09:42 ET | 752 | 17.085 |
09:46 ET | 756 | 17.215 |
09:48 ET | 100 | 17.38 |
09:50 ET | 200 | 17.35 |
09:51 ET | 1603 | 17.21 |
09:53 ET | 112 | 17.21 |
09:55 ET | 300 | 17.26 |
10:00 ET | 1272 | 17.24 |
10:02 ET | 300 | 17.175 |
10:04 ET | 327 | 17.19 |
10:06 ET | 3352 | 17.18 |
10:08 ET | 600 | 17.2 |
10:09 ET | 4436 | 17.195 |
10:11 ET | 200 | 17.195 |
10:13 ET | 100 | 17.23 |
10:15 ET | 3597 | 17.19 |
10:18 ET | 1365 | 17.26 |
10:20 ET | 200 | 17.275 |
10:22 ET | 2829 | 17.3 |
10:24 ET | 600 | 17.35 |
10:26 ET | 300 | 17.32 |
10:27 ET | 4261 | 17.14 |
10:29 ET | 3074 | 17.185 |
10:31 ET | 500 | 17.15 |
10:33 ET | 339 | 17.12 |
10:36 ET | 1667 | 17.08 |
10:38 ET | 200 | 17.07 |
10:40 ET | 1839 | 17.15 |
10:42 ET | 100 | 17.16 |
10:44 ET | 100 | 17.09 |
10:45 ET | 1700 | 16.98 |
10:47 ET | 100 | 16.985 |
10:49 ET | 100 | 16.91 |
10:51 ET | 1096 | 16.95 |
10:54 ET | 300 | 16.9 |
10:56 ET | 1138 | 16.95 |
11:00 ET | 1024 | 16.92 |
11:03 ET | 1528 | 16.955 |
11:05 ET | 100 | 17 |
11:07 ET | 100 | 16.99 |
11:12 ET | 200 | 16.965 |
11:14 ET | 1400 | 16.95 |
11:16 ET | 1965 | 17.055 |
11:18 ET | 507 | 17.08 |
11:20 ET | 100 | 17.11 |
11:21 ET | 200 | 17.055 |
11:23 ET | 100 | 17.09 |
11:25 ET | 300 | 17.055 |
11:27 ET | 1411 | 17.12 |
11:30 ET | 1100 | 17.16 |
11:32 ET | 100 | 17.16 |
11:34 ET | 900 | 17.12 |
11:36 ET | 800 | 17.07 |
11:38 ET | 1000 | 17.09 |
11:39 ET | 800 | 17.07 |
11:41 ET | 600 | 17.115 |
11:43 ET | 100 | 17.1 |
11:48 ET | 1343 | 17.0962 |
11:50 ET | 2602 | 17.14 |
11:52 ET | 300 | 17.17 |
11:54 ET | 400 | 17.16 |
11:56 ET | 3677 | 17.21 |
11:57 ET | 810 | 17.315 |
11:59 ET | 1058 | 17.3675 |
12:03 ET | 200 | 17.32 |
12:06 ET | 200 | 17.29 |
12:08 ET | 1000 | 17.3101 |
12:10 ET | 2436 | 17.32 |
12:12 ET | 500 | 17.35 |
12:17 ET | 679 | 17.37 |
12:19 ET | 1650 | 17.38 |
12:21 ET | 1034 | 17.47 |
12:24 ET | 100 | 17.43 |
12:26 ET | 200 | 17.43 |
12:28 ET | 100 | 17.42 |
12:30 ET | 1557 | 17.375 |
12:32 ET | 100 | 17.36 |
12:33 ET | 800 | 17.45 |
12:35 ET | 300 | 17.48 |
12:37 ET | 600 | 17.43 |
12:39 ET | 356 | 17.435 |
12:44 ET | 200 | 17.46 |
12:46 ET | 1551 | 17.5 |
12:48 ET | 510 | 17.51 |
12:50 ET | 1900 | 17.54 |
12:51 ET | 334 | 17.53 |
12:53 ET | 300 | 17.49 |
12:55 ET | 700 | 17.435 |
12:57 ET | 884 | 17.49 |
01:00 ET | 482 | 17.51 |
01:02 ET | 400 | 17.52 |
01:04 ET | 200 | 17.52 |
01:06 ET | 200 | 17.52 |
01:09 ET | 845 | 17.525 |
01:11 ET | 700 | 17.51 |
01:13 ET | 894 | 17.515 |
01:15 ET | 200 | 17.53 |
01:18 ET | 1191 | 17.595 |
01:20 ET | 304 | 17.63 |
01:22 ET | 102 | 17.66 |
01:24 ET | 804 | 17.64 |
01:26 ET | 610 | 17.66 |
01:27 ET | 1700 | 17.61 |
01:29 ET | 600 | 17.62 |
01:31 ET | 800 | 17.62 |
01:33 ET | 200 | 17.62 |
01:36 ET | 525 | 17.62 |
01:38 ET | 700 | 17.62 |
01:40 ET | 408 | 17.59 |
01:42 ET | 200 | 17.59 |
01:44 ET | 400 | 17.62 |
01:45 ET | 1571 | 17.57 |
01:47 ET | 2058 | 17.58 |
01:49 ET | 500 | 17.58 |
01:51 ET | 700 | 17.53 |
01:54 ET | 251 | 17.53 |
01:56 ET | 400 | 17.515 |
01:58 ET | 600 | 17.46 |
02:00 ET | 200 | 17.47 |
02:02 ET | 1100 | 17.4501 |
02:03 ET | 740 | 17.49 |
02:05 ET | 400 | 17.46 |
02:07 ET | 400 | 17.44 |
02:09 ET | 981 | 17.47 |
02:12 ET | 261 | 17.48 |
02:14 ET | 400 | 17.48 |
02:18 ET | 200 | 17.455 |
02:20 ET | 957 | 17.47 |
02:21 ET | 1038 | 17.51 |
02:23 ET | 1832 | 17.42 |
02:25 ET | 200 | 17.41 |
02:27 ET | 122 | 17.405 |
02:32 ET | 600 | 17.35 |
02:36 ET | 1230 | 17.365 |
02:38 ET | 100 | 17.35 |
02:39 ET | 3831 | 17.41 |
02:41 ET | 1189 | 17.48 |
02:43 ET | 781 | 17.55 |
02:45 ET | 564 | 17.55 |
02:48 ET | 600 | 17.51 |
02:50 ET | 100 | 17.515 |
02:52 ET | 950 | 17.44 |
02:54 ET | 1243 | 17.5 |
02:56 ET | 400 | 17.47 |
02:57 ET | 883 | 17.435 |
02:59 ET | 100 | 17.435 |
03:01 ET | 937 | 17.385 |
03:03 ET | 200 | 17.37 |
03:06 ET | 328 | 17.39 |
03:08 ET | 500 | 17.29 |
03:10 ET | 1511 | 17.38 |
03:12 ET | 100 | 17.38 |
03:15 ET | 2055 | 17.4 |
03:17 ET | 1893 | 17.3825 |
03:19 ET | 100 | 17.3825 |
03:21 ET | 614 | 17.36 |
03:24 ET | 100 | 17.36 |
03:26 ET | 1592 | 17.39 |
03:28 ET | 1400 | 17.35 |
03:30 ET | 100 | 17.35 |
03:32 ET | 770 | 17.305 |
03:33 ET | 847 | 17.3 |
03:35 ET | 600 | 17.31 |
03:37 ET | 956 | 17.31 |
03:39 ET | 5190 | 17.4 |
03:42 ET | 5256 | 17.4 |
03:44 ET | 19427 | 17.46 |
03:48 ET | 1726 | 17.38 |
03:50 ET | 1415 | 17.375 |
03:51 ET | 2178 | 17.42 |
03:53 ET | 6422 | 17.37 |
03:55 ET | 3485 | 17.39 |
03:57 ET | 7955 | 17.36 |
04:00 ET | 86387 | 17.42 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.6B | -5.5x | --- |
Travere Therapeutics Inc | 1.6B | -4.1x | --- |
Nurix Therapeutics Inc | 1.6B | -7.6x | --- |
Arvinas Inc | 1.7B | -5.1x | --- |
Ardelyx Inc | 1.2B | -16.9x | --- |
Arcutis Biotherapeutics Inc | 1.5B | -7.3x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
---|---|
Revenue (TTM) | $263.0M |
Shares Outstanding | 91.5M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.85 |
EPS | $-3.15 |
Book Value | $6.12 |
P/E Ratio | -5.5x |
Price/Sales (TTM) | 6.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -120.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.